FindTrial
Sign In

A Multicenter Clinical Study of Acoustic Thrombolysis for Improvement of Myocardial Microcirculatory Perfusion and Prognosis in Patients with Acute Myocardial Infarction

A Multicenter Clinical Study of Acoustic Thrombolysis for Improvement of Myocardial Microcirculatory Perfusion and Prognosis in Patients with Acute Myocardial Infarction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015843
Enrollment
Unknown
Registered
2018-04-24
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

The treated group:PCI + acoustic thrombolysis
The control group:PCI

Sponsors

Department of Cardiology, Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Chest pain over 30 minutes, but accept PCI in 12 hours; (2) ST elevation>0.1 mV in more than 2 adjacent leads; (3) Aged from 18 to 80 and able to give written informed consent.

Exclusion criteria

Exclusion criteria: (1) Previously diagnosed as myocardial infarction; (2) Suspected or previously allergy to perflutren; (3) Pregnant and lactating; (4) fail to complete their follow-up; (5) attending Other clinical trials; (6) with mental disorders; (7) has been thrombolytic prior to PCI; (8) with severe pulmonary hypertension; (9) Hemodynamic instability.

Design outcomes

Primary

MeasureTime frame
Myocardial microcirculation perfusion scoring;4/5000 Shè xuè fenshù Ejection fraction;Cardiovascular death;—

Countries

China

Contacts

Public ContactBin Jianping

Department of Cardiology, Nanfang Hospital, Southern Medical University

jianpingbin@126.com+86 18680488488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026